Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000294

Drug Information
NameTriflupromazine
SynonymsN,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine hydrochloride; NCI60_001029; NINDS_000808; Trifluopromazine hydrochloride; Vesprin; N,N-dimethyl-3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)-1-propanamine; Fluopromazine; Lopac-T-2896; Fluorofen; NCGC00016012-01; Spectrum_000095; C18H19F3N2S; Neoprin; KBio1_000808; AC1L1KMZ; PDSP1_001344; BPBio1_000227; 2-(Trifluoromethyl)promazine; EINECS 205-673-6; BSPBio_000205; 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine; AB00053647; UNII-RO16TQF95Y; Lopac0_001146; BSPBio_003444; KBio2_000515; N,N-Dimethyl-2-(trifluoromethyl)-10H-phenothiazine-10-propanamine; Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-; N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-amine; Triflupromazina [INN-Spanish]; DB00508; nchembio873-comp69; PDSP2_001328; CHEBI:9711; NSC17473; Siquil; Triflupromazinum; AR-1K7464; Triflupromazinum [INN-Latin]; SPBio_002126; 146-54-3; NCGC00016012-09; Prestwick0_000053; DivK1c_000808; CHEMBL570; CID5568; HSDB 3407; Adazine; Nivoman; L001149; KBioSS_000515; 10-3-(Dimethylamino)propyl-2-(trifluoromethyl)phenothiazine; D00390; Triflupromazine [INN]; CAS-1098-60-8; Fluopromazine monohydrochloride; NCGC00024300-04; Spectrum5_001282; NCGC00016012-03; KBio2_003083; 2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine; N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine; Triflupromazina; Prestwick3_000053; KBioGR_001062; Psyquil; Vetame; KBio2_005651; Triflupromazine (USP/INN); NSC14959; triflupromazine; 10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-; Spectrum4_000741; LS-105500; NCGC00016012-02; Prestwick1_000053; Trifluopromazine; Prestwick2_000053; Vesprin (TN); NCI60_001426; IDI1_000808; AC1Q4JZU
Trade NameVesprin
CompanyBristol-Myers Squibb
IndicationPsychoses
[ICD9: 290-299   ICD10: F20-F29]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(1
2-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3
InChIKeyXSCGXQMFQXDFCW-UHFFFAOYSA-N
Canonical SMILESCN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F    
Therapeutic ClassAntipsychotic Agents
CAS NumberCAS 146-54-3
FormulaC18H19F3N2S
PubChem Compound IDCID 5568.
PubChem Substance IDSID 152129.
ChEBI9711;
SuperDrug ATC IDN05AA05
SuperDrug CAS ID000146543;
Target5-hydroxytryptamine 2B receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 011123 To Reference
Ref 2Some properties of 5-hydroxytryptamine receptors in the hindquarters of the rat. Br J Pharmacol. 1979 Sep;67(1):79-85. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543